Just stuff I found of significance
- Revenue from China expected to be roughly maintained in the next quarter, NMPA expected June-December (Which year Rob!
).
- More literature over weekend that supports importance of cardiovascular monitoring in COVID-19.
- More mentions of their aim to eventually import third party devices into China.
- Suggested revenue in Europe to be poor until COVID eases(Aren't they still waiting on CE renewal as well?).
- US is an unknown due to change in sales model. Assumption is next 6 months US will push for short term solutions. Mid-term we could benefit.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable